Robert Hoffman
Directeur Général chez KINTARA THERAPEUTICS, INC.
Fortune : 117 368 $ au 30/04/2024
Profil
Robert E.
Hoffman is currently the Chairman, President, Chief Executive Officer & CFO at Kintara Therapeutics, Inc. He is also an Independent Director at ASLAN Pharmaceuticals Pte Ltd., an Independent Non-Executive Director at Aslan Pharmaceuticals Ltd., a Director at Day For Change, and an Independent Director at FibroBiologics, Inc. In his former positions, Mr. Hoffman served as the Chairman at Antibe Therapeutics, Inc. from 2020 to 2024.
He was also a Director at Telik, Inc., an Independent Director at CombiMatrix Corp., a Director at Zeta Acquisition Corp.
III, an Independent Director at Kura Oncology, Inc., an Independent Director at Versartis, Inc., the President & Director at Financial Executives International of San Diego Chapter from 2010 to 2020, an Independent Director at Saniona AB from 2021 to 2022, an Independent Director at MabVax Therapeutics Holdings, Inc. from 2014 to 2017, an Independent Director at Aravive, Inc. from 2018 to 2020, the Chief Financial Officer & Senior VP-Finance at Heron Therapeutics, Inc. from 2017 to 2020, and an Assistant Controller at Document Sciences Corp.
from 1994 to 1997.
He also served as the Chief Financial Officer & Senior VP-Finance at Arena Pharmaceuticals, Inc. from 1997 to 2015, the Chief Financial Officer at AnaptysBio, Inc. from 2015 to 2016, the Chief Financial & Accounting Officer, Executive VP at Innovus Pharmaceuticals, Inc. from 2016 to 2017, and the Chief Financial Officer at Polaris Group, Inc. in 2011.
Mr. Hoffman obtained his undergraduate degree from St. Bonaventure University in 1988.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
FIBROBIOLOGICS, INC.
0,02% | 24/01/2024 | 7 500 ( 0,02% ) | 87 600 $ | 30/04/2024 |
| 01/04/2024 | 150 000 ( 0,04% ) | 13 440 $ | 30/04/2024 | |
| 14/09/2023 | 68 902 ( 0,12% ) | 10 887 $ | 30/04/2024 | |
| 11/01/2024 | 38 334 ( 0,07% ) | 5 441 $ | 30/04/2024 |
Postes actifs de Robert Hoffman
| Sociétés | Poste | Début |
|---|---|---|
| KINTARA THERAPEUTICS, INC. | Directeur Général | 08/11/2021 |
| ASLAN PHARMACEUTICALS LIMITED | Directeur/Membre du Conseil | 30/10/2018 |
| FIBROBIOLOGICS, INC. | Directeur/Membre du Conseil | 08/04/2021 |
ASLAN Pharmaceuticals Pte Ltd.
 ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Directeur/Membre du Conseil | - |
| Day For Change | Directeur/Membre du Conseil | - |
Anciens postes connus de Robert Hoffman
| Sociétés | Poste | Fin |
|---|---|---|
| ANTIBE THERAPEUTICS INC. | Président | 24/04/2024 |
| SANA AB | Directeur/Membre du Conseil | 25/05/2022 |
| KURA ONCOLOGY, INC. | Directeur/Membre du Conseil | 03/08/2021 |
| HERON THERAPEUTICS, INC. | Directeur Financier/CFO | 16/10/2020 |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Robert Hoffman
| St. Bonaventure University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 9 |
|---|---|
| ANAPTYSBIO, INC. | Health Technology |
| KURA ONCOLOGY, INC. | Health Technology |
| HERON THERAPEUTICS, INC. | Health Technology |
| KINTARA THERAPEUTICS, INC. | Health Technology |
| ARAVIVE, INC. | Health Technology |
| ASLAN PHARMACEUTICALS LIMITED | Health Technology |
| ANTIBE THERAPEUTICS INC. | Health Technology |
| SANA AB | Health Technology |
| FIBROBIOLOGICS, INC. | Health Technology |
| Entreprise privées | 12 |
|---|---|
Polaris Group, Inc.
 Polaris Group, Inc. Real Estate DevelopmentFinance Polaris Group is a sales, marketing and consulting firm with experience in bringing new residential real estate to market in the San Francisco Bay Area and Southern California. Polaris Group has three distinct divisions: Polaris Analytics, Polaris Marketing and Polaris Sales. From land acquisition, market research and entitlements, to architectural review, brand development and escrow coordination, Polaris Group analyzes each new home community and attempts to maximize builder opportunities. Their approach is based on constant evaluation of pricing trends, new product supply pipelines, construction pricing and market conditions. | Finance |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
| Financial Executives International of San Diego Chapter | |
CombiMatrix Corp.
 CombiMatrix Corp. BiotechnologyHealth Technology CombiMatrix Corp. engages in the provision of clinical diagnostic services. It offers cytogenomic testing for preimplantation genetic testing, prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. The company was founded in October 1995 and is headquartered in Irvine, CA. | Health Technology |
Telik, Inc.
 Telik, Inc. Pharmaceuticals: MajorHealth Technology Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA. | Health Technology |
MabVax Therapeutics Holdings, Inc.
 MabVax Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology MabVax Therapeutics Holdings, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing innovative vaccine and monoclonal antibody-based therapeutics for the diagnosis and treatment of cancer. The company was founded on July 8, 2014 and is headquartered in San Diego, CA. | Health Technology |
Zeta Acquisition Corp. III
 Zeta Acquisition Corp. III MiscellaneousMiscellaneous Zeta Acquisition Corp. III operates as a blank check company. It was organized as a vehicle to investigate and, if such investigation warrants, acquire a target company or business seeking the perceived advantages of being a publicly held corporation. The firm will not restrict its potential candidate target companies to any specific business, industry or geographical location and, thus, may acquire any type of business. The company was founded on November 16, 2007 and is headquartered in Des Moines, IA. | Miscellaneous |
Document Sciences Corp.
 Document Sciences Corp. Packaged SoftwareTechnology Services Document Sciences Corp. developed software for customer communications management solutions. Its products included xPression and Autograph, which enable automated publishing solutions for insurance, financial services, healthcare, manufacturing, distribution, government, and commercial outsourcing industries. The company was founded in 1991 and was headquartered in Carlsbad, CA. | Technology Services |
Innovus Pharmaceuticals, Inc.
 Innovus Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Innovus Pharmaceuticals, Inc. engages in the commercialization, licensing, and development of non-prescription medicine, and consumer care products for health and vitality, and respiratory diseases. Its products focuses in six main categories, including sexual health, pain management, general muscle health, respiratory, sleep, and diabetic care. The company was founded on January 15, 1959 and is headquartered in Englewood, CO. | Health Technology |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Health Technology |
| Day For Change | |
ASLAN Pharmaceuticals Pte Ltd.
ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Health Technology |
